Stem cell therapy for hard-to-treat type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests a new stem cell treatment for people with type 2 diabetes that is difficult to control with standard medications. The treatment uses a special kind of stem cell to try to improve blood sugar levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 30 and 75 years old
- You have type 2 diabetes with a fasting blood sugar of 7.0 mmol/L or higher
- Your body mass index (BMI) is between 20 and 30
- Your blood sugar control (measured by A1c) is between 7.5% and 10%
- You have been using insulin injections for at least 6 months and your other diabetes drugs have been stable for 3 months
- You are willing to use effective birth control during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if umbilical cord stem cells can improve the success of islet cell transplants for people with diabetes whose own pancreas no longer makes enough insulin. It aims to help patients achieve better blood sugar control and reduce dangerous low blood sugar episodes.
This trial tests whether infusing stem cells from umbilical cord blood can help slow kidney damage caused by type 2 diabetes. You would receive the stem cells through an IV, and researchers will monitor your kidney function over time.
This trial tests whether transplanting your own insulin-making cells (islets) can help control blood sugar if you have type 2 diabetes and your pancreas is not making enough insulin. The goal is to reduce or stop your need for insulin injections.
This study tests an experimental stem cell treatment (DT2-SCT) to see if it can improve blood sugar control in people with type 2 diabetes who need insulin. It is a double-blind study, so neither you nor the study team will know if you get the real treatment or a placebo.
This trial tests a new type of cell therapy called cfMSC for people with type 2 diabetes. The goal is to see if it can help control blood sugar better, possibly by helping the body use insulin more effectively.
This trial tests if a type of stem cell product (exosomes) can safely and effectively help people with type 2 diabetes. Researchers will give infusions to see if it improves blood sugar control and pancreatic function.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.